1. Yu C, Li L, Chen W, Jiao Y, Yang N, Yang E, Zhang J, Chen L, Li Y. Levofloxacin susceptibility testing for Helicobacter pylori in China: comparison of E-test and disk diffusion method. Helicobacter. 2011; 16:119-23. [
DOI:10.1111/j.1523-5378.2011.00820.x] [
PMID]
2. Ayala G, Escobedo-Hinojosa WI, de la Cruz-Herre- ra CF, Romero I. Exploring alternative treatments for Helicobacter pylori infection. World J Gastroenterol 2014; 20:1450-69. [
DOI:10.3748/wjg.v20.i6.1450] [
PMID] [
PMCID]
3. Yamaoka Y, Kato M, Asaka M .2008. Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med 47: 1077-83. [
DOI:10.2169/internalmedicine.47.0975] [
PMID] [
PMCID]
4. Polk DB, Peek Jr RM. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 2010; 10:403-14. [
DOI:10.1038/nrc2857] [
PMID] [
PMCID]
5. Mendoza JA, Weinberger KK, Swan MJ. The Hsp60 protein of Helicobacter pylori displays chaperone ac- activity under acidic conditions. Biochem Biophys Rep2017; 9:95-9. [
DOI:10.1016/j.bbrep.2016.11.011] [
PMID] [
PMCID]
6. Prasertpetmanee S, Mahachai V, Vilaichone RK. Improved efficacy of proton pump inhibitor - amoxicillin - clarithromycin triple therapy for Helicobacter pylori eradication in low clarithromycin resistance areas or tailored therapy. Helicobacter. 2013; 18:270-3. [
DOI:10.1111/hel.12041] [
PMID]
7. Atherton JC, EM Omar-El, JL Hale, RH A. In Differences. at motif phosphorylation tyrosine CagA pylori H on influences and, strains Asian East and western between. Microbiol Med J 2008; 7(10): 57 - 62.
8. Thung I, Aramin H, Vavinskaya V, Gupta S, Park JY, Crowe SE, Valasek MA. Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther. 2016;43:514-33.
https://doi.org/10.1111/apt.13625 [
DOI:10.1111/apt.13497]
9. Pellicano R, Ribaldone DG, Fagoonee S, Astegiano M, Saracco GM, Mégraud F. A 2016 panorama of Helicobacter pylori infection: key messages for clinicians. Panminerva Med. 2016;58:304-17.
10. Falsafi T, Ehsani A, Niknam V. The role of active efflux in antibiotic - resistance of clinical isolates of Helicobacter pylori. Indian J Med Microbiol. 2009;27:335-40. [
DOI:10.4103/0255-0857.55452] [
PMID]
11. Abolghasem Tohidpour. CagA-mediated pathogenesis of Helicobacter pylori, Microb Pathog 93 (2016) 44e55. [
DOI:10.1016/j.micpath.2016.01.005] [
PMID]
12. Megraud FM and Lehours P. "Helicobacter pylori detection and antimicrobial susceptibility testing," Clini Microbiol Rev. 2007; 20(2): 280-322. [
DOI:10.1128/CMR.00033-06] [
PMID] [
PMCID]
13. Jafari F, Aslani M, Shokrzadeh L, Baghai K, Dabiri H, Zojaji H, Razavilar V, Kharaziha P, Haghazali M, Molaei M, Zali MR. Distribution of UreC, CagA, and vacA genes in Helicobacter pylori isolated from patients with gastroduodenal disease in Tehran, Iran. Europ Soc Clin Microbiol Infect Dis 2007. [
DOI:10.1016/S0924-8579(07)71682-5]
14. Krashias G, Bashiardes S, Potamitou A, Potamitis GS, Christodoulou Ch. Prevalence of Helicobacter pylori CagA and vacA genes in Cypriot patients. J Infect Dev Ctries 2012; 7(9):642-650. [
DOI:10.3855/jidc.2923] [
PMID]
15. Hussein NR, Mohammadi M, Talebkhan Y, Doraghi M, Letley DP, Muhammad MK, et al. Differencesin virulence markers between Helicobacter pylori strains from Iraq and those from Iran: potential importance of regional differences in H. pylori-associated disease, Journal of Clinical Microbiology 2008; 46(5): 1774-1779. [
DOI:10.1128/JCM.01737-07]
16. Essawi T, Hammoudeh W, Sabri I, Sweidan W, and Farraj M A. Determination of Helicobacter pylori Virulence Genes in Gastric Biopsies by PCR. Hindawi Publishing Corporation ISRN Gastroenterology 2013; 16:119-123. [
DOI:10.1155/2013/606258] [
PMID] [
PMCID]
، فاطمه کشاورزی 
